Quince Therapeutics, Inc. (QNCX)
Market Open
9 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
31. 73
+2.37
+8.0722%
$
8.83M Market Cap
- P/E Ratio
- Div Yield
138,744 Volume
0 Eps
$ 29.36
Previous Close Want to track QNCX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Quince Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Caroline Jankowski Operose Advisors LLC | 159 | $146.36 | $4,770 | $4,623.64 | 3,159.09% |
 Drew Phillips Fortitude Family Office LLC | 41 | $67.82 | $1,300.93 | $1,233.11 | 1,818.21% |
 Jeffrey D. Munjack JDM Financial Group LLC | 1 | $0.92 | $30 | $29.08 | 3,160.87% |
 David Millar Gen-Wealth Partners Inc | 165 | $151.88 | $4,950 | $4,798.12 | 3,159.15% |
2026 © Marketlog. All Rights Reserved.
